Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
RayzeBio, Inc. | 10%+ Owner | Common Stock | 5.16M | $322M | $62.50 | Sep 19, 2023 | Direct |
Elevation Oncology, Inc. | 10%+ Owner | Common Stock | 1.91M | $972K | $0.51 | May 25, 2022 | Direct |
Artiva Biotherapeutics, Inc. | 10%+ Owner | Common Stock | 1.94M | Jul 22, 2024 | Direct | ||
Ventyx Biosciences, Inc. | Other*, 10%+ Owner | Stock Option (right to buy) | 13.3K | Jun 9, 2022 | Indirect | ||
Artiva Biotherapeutics, Inc. | 10%+ Owner | Series A Convertible Preferred Stock | 0 | Jul 22, 2024 | Direct | ||
Artiva Biotherapeutics, Inc. | 10%+ Owner | Series B Convertible Preferred Stock | 0 | Jul 22, 2024 | Direct | ||
RayzeBio, Inc. | 10%+ Owner | Series A Convertible Preferred Stock | 0 | Sep 19, 2023 | Direct | ||
RayzeBio, Inc. | 10%+ Owner | Series B Convertible Preferred Stock | 0 | Sep 19, 2023 | Direct | ||
RayzeBio, Inc. | 10%+ Owner | Series C Convertible Preferred Stock | 0 | Sep 19, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ARTV | Artiva Biotherapeutics, Inc. | Jul 22, 2024 | 6 | $5M | 4 | Jul 22, 2024 | 10%+ Owner |
ARTV | Artiva Biotherapeutics, Inc. | Jul 18, 2024 | 0 | $0 | 3 | Jul 18, 2024 | 10%+ Owner |
RYZB | RayzeBio, Inc. | Sep 19, 2023 | 6 | $0 | 4 | Sep 21, 2023 | 10%+ Owner |
RYZB | RayzeBio, Inc. | Sep 14, 2023 | 0 | $0 | 3 | Sep 14, 2023 | 10%+ Owner |
VTYX | Ventyx Biosciences, Inc. | Jun 9, 2022 | 2 | $0 | 4 | Jun 10, 2022 | Other*, 10%+ Owner |
ELEV | Elevation Oncology, Inc. | May 25, 2022 | 1 | -$2.9M | 4 | May 27, 2022 | 10%+ Owner |
VTYX | Ventyx Biosciences, Inc. | Oct 25, 2021 | 4 | $5M | 4 | Oct 25, 2021 | Other*, 10%+ Owner |
VTYX | Ventyx Biosciences, Inc. | Oct 20, 2021 | 0 | $0 | 3 | Oct 20, 2021 | Other*, 10%+ Owner |
ELEV | Elevation Oncology, Inc. | Jun 29, 2021 | 3 | $10M | 4 | Jul 1, 2021 | 10%+ Owner |
ELEV | Elevation Oncology, Inc. | Jun 24, 2021 | 0 | $0 | 3 | Jun 24, 2021 | 10%+ Owner |